Successful Health Strategies

Successful Health Care Provider Strategies to Overcome Psychological Insulin Resistance in United States and Canada

Authors: Tricia Tang, Danielle Hessler, William H Polonsky, Lawrence Fisher, Beverly Reed, Tanya Irani, Urvi Desai, Magaly Perez-Nieves

Abstract

Purpose: To identify specific actions and characteristics of health care providers (HCPs) in the United States and Canada that influenced patients with type 2 diabetes who were initially reluctant to begin insulin.

Methods: Patients from the United States (n = 120) and Canada (n = 74) were recruited via registry, announcements, and physician referrals to complete a 30-minute online survey based on interviews with patients and providers regarding specific HCP actions that contributed to the decision to begin insulin.

Results: The most helpful HCP actions were patient-centered approaches to improve patients’ understanding of the injection process (ie, “My HCP walked me through the whole process of exactly how to take insulin” [helped moderately or a lot, United States: 79%; Canada: 83%]) and alleviate concerns (“My HCP encouraged me to contact his/her office immediately if I ran into any problems or had questions after starting insulin” [United States: 76%; Canada: 82%]). Actions that were the least helpful included referrals to other sources (ie, “HCP referred patient to a class to help learn more about insulin” [United States: 40%; Canada: 58%]).

Conclusions: The study provides valuable insight that HCPs can use to help patients overcome psychological insulin resistance, which is a critical step in the design of effective intervention protocols.

Source: https://pubmed.ncbi.nlm.nih.gov/32179603/

Share the Post:

BDI Monthly Events

March 12Case Consultation Meeting
March 12: BDI hosts the San Diego-wide, monthly case consultation meeting (for mental health professionals working in the field of diabetes). Contact us at [email protected] if you are in the greater San Diego area and would like further information about this program.
March 19-22International Conference
18th International Conference for ATTD (Advanced Technologies and Treatments for Diabetes) in Amsterdam, Dr. Polonsky (BDI President) has three presentations.
March 19Type 2 Presentation
On March 19, Dr. Polonski will present CGM is Wonderful, But… at the Roche-sponsored symposium, “Translating the Power of Prediction into Diabetes Management”, and Insulin Therapy Experience: Considering the Needs of People Living with Diabetes (with Professor Cukierman-Yaffe) at the Sanofi-sponsored symposium, Confidence and Simplicity in Diabetes Management”. https://attd.kenes.com/
March 20Type 2 Presentation
On March 20, Dr. Polonski will present Improved Patient- and Physician-Reported Outcomes with IGlarLixi When Switching From Premixed Insulin in People with Type 2 Diabetes: The Soli-Switch Study. https://cslide.ctimeetingtech.com/attd25/attendee/confcal/session/calendar/2025-03-20